Back to Search Start Over

LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation

Authors :
P.A. Jänne
E.F. Smit
F. de Marinis
J. Laskin
M. Domine Gomez
S. Gadgeel
M.C. Garassino
S. Lu
A.S. Spira
V. Kang
S. Roshan
X. Yan
E. Felip
Source :
Immuno-Oncology and Technology. 16:100360
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Immunology and Allergy

Details

ISSN :
25900188
Volume :
16
Database :
OpenAIRE
Journal :
Immuno-Oncology and Technology
Accession number :
edsair.doi...........7abd92067fb63c206a7206d52807baad
Full Text :
https://doi.org/10.1016/j.iotech.2022.100360